Biotech
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 10/21/14 -- Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima" or "the Company") advises that the Company will host a shareholder conference ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 10/21/14 -- Flamel Technologies (NASDAQ: FLML) will release financial results for the third quarter of fiscal year 2014 on Friday, October 31, 2014, before the market ...
HALIFAX, NOVA SCOTIA: All Animals Receiving a Single Dose of DepoVax(TM) Formulated Anthrax Vaccine Survive; Significant Immune Response Detected as Early as 14 Days Following Vaccination ...
LONDON, ONTARIO: Initial results suggest that COTI-2 has potential for another unmet cancer need ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/21/14 -- InMed Pharmaceuticals ("InMed") is pleased to announce the completion of its name change and effective immediately will no longe ...
HUDSON, NY: Excluded Flora Standard Allows for Models Free of Two Additional Commensal Organisms ...
TACOMA, WA: Adds Proven Industry Leadership to Accelerate RNS60 Commercialization ...
TACOMA, WA: Multiple Published Research Studies Outline the Potential for RNS60 to Effectively Treat Alzheimer's Disease by Protecting Neuronal Function and Restoring Neuronal Plasticity ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 10/20/14 -- -- Mikroscan Technologies, a pioneer in desktop whole-slide scanning systems for pathology, biology and research applications, continues its leadersh ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 10/20/14 -- Proteostasis Therapeutics, Inc., a company developing novel therapeutics to address diseases caused by defects in protein folding, trafficking and cleara ...
LONDON, ONTARIO: Increases Runway Into the Clinic for Lead Cancer Drug Candidate COTI-2 ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 10/17/14 -- Celmatix, a privately held personalized medicine company focused on maximizing lifelong fertility, today announced the appointment of David L. Stern to Ch ...
LAS VEGAS, NEVADA: LAS VEGAS, NEVADA -- (Marketwired) -- 10/17/14 -- Cell MedX Corp. (OTCBB: CMXC), (the "Company") is pleased to announce that on October 16, 2014, the Company entered into a Technology Purc ...
DUBLIN, IRELAND: Acquisition Bolsters Primary Care Product Portfolio; Horizon to Host Conference Call/Webcast at 8:00 a.m. EST ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/15/14 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its third quarter 2014 operational and fin ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/15/14 -- Arch Biopartners Inc ("Arch" or the "Company") (CSE: ACH)(OTCBB: FOIFF) announced today the introduction of Metablok, a new drug ...
SAN DIEGO, CA: Dr. Patel to Apply His Experience in Over 17 FDA Trials to Accelerate Development of HemaXellerate and dCellVax ...
LONDON, ONTARIO: P53-Dependent Cancer Treatment IP Coverage Extended to Home Market ...
LAVAL, QUEBEC: - Follows positive review of PBI-4050 data by external IPF panel of experts - IPF clinical program to commence in Q4 2014 ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 10/14/14 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") is pleased to announce that Immutep S.A. ("Immutep" ...
